Yeji
FDA approvaloutcome: successconf 1.00

brineura — FDA approval

$BMRN · BIOMARIN PHARMACEUTICAL INC
Event date
July 24, 2024
682 days ago
Sponsor runway
cash-flow +
$2.22B liquid

Evidence

openFDA SUPPL (EFFICACY) approval of BRINEURA — application BLA761052

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

19 insiders · 0 buys · 8 sells
Grant
2024-09-30
Friberg Gregory R
EVP, Chief R&D Officer
49,850 @
Grant
2024-09-30
Friberg Gregory R
EVP, Chief R&D Officer
7,870 @
Grant
2024-09-30
Friberg Gregory R
EVP, Chief R&D Officer
21,190 @
Tax
2024-09-13
FUCHS HENRY J
President, Worldwide R&D
12,098 @ $84.90$1.03M
Sell10b5-1
2024-08-13
Burkhart Erin
GVP, Chief Accounting Officer
714 @ $90.00$64K
Tax
2024-06-28
Mueller Brian
EVP, Chief Financial Officer
588 @ $82.33$48K
Tax
2024-06-03
HERON ELAINE J
Director
4,168 @ $76.41$318K
Exercise
2024-06-03
HERON ELAINE J
Director
5,047 @ $63.10$318K
Tax
2024-06-03
MEIER RICHARD A
Director
5,451 @ $76.41$417K
Exercise
2024-06-03
MEIER RICHARD A
Director
6,600 @ $63.10$416K
Exercise10b5-1
2024-05-30
Mueller Brian
EVP, Chief Financial Officer
5,000 @ $63.10$316K
Sell10b5-1
2024-05-30
Mueller Brian
EVP, Chief Financial Officer
5,000 @ $75.19$376K
Exercise10b5-1
2024-05-28
Davis George Eric
EVP, Chief Legal Officer
40,850 @ $63.10$2.58M
Sell10b5-1
2024-05-28
Davis George Eric
EVP, Chief Legal Officer
38,071 @ $74.45$2.83M
Sell10b5-1
2024-05-28
Davis George Eric
EVP, Chief Legal Officer
2,779 @ $75.29$209K
Grant
2024-05-21
Dere Willard H
Director
4,720 @
Grant
2024-05-21
HERON ELAINE J
Director
4,720 @
Grant
2024-05-21
MEIER RICHARD A
Director
7,080 @
Grant
2024-05-21
Bodem Barbara W.
Director
4,720 @
Grant
2024-05-21
ANDERSON ELIZABETH M
Director
4,720 @
Grant
2024-05-21
PYOTT DAVID E I
Director
4,720 @
Grant
2024-05-21
Countouriotis Athena
Director
4,720 @
Grant
2024-05-21
Enyedy Mark J
Director
4,720 @
Grant
2024-05-21
HOMBACH ROBERT J.
Director
4,720 @
Grant
2024-05-21
Ho Maykin
Director
4,720 @
Grant
2024-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
4,700 @
Grant
2024-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
14,690 @
Grant
2024-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
33,520 @
Tax
2024-05-20
BIENAIME JEAN JACQUES
Director
1,202 @ $77.05$93K
Tax
2024-05-17
Burkhart Erin
GVP, Chief Accounting Officer
993 @ $76.97$76K
Exercise10b5-1
2024-05-10
BIENAIME JEAN JACQUES
Director
20,000 @ $63.10$1.26M
Sell10b5-1
2024-05-10
BIENAIME JEAN JACQUES
Director
20,000 @ $81.14$1.62M
Exercise10b5-1
2024-05-09
BIENAIME JEAN JACQUES
Director
20,000 @ $63.10$1.26M
Sell10b5-1
2024-05-09
BIENAIME JEAN JACQUES
Director
20,000 @ $81.62$1.63M
Tax
2024-05-03
Guyer Charles Greg
EVP, Chief Technical Officer
4,440 @ $82.44$366K
Sell10b5-1
2024-05-02
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
5,000 @ $82.91$415K
Exercise10b5-1
2024-05-02
Davis George Eric
EVP, Chief Legal Officer
1,850 @ $63.10$117K
Sell10b5-1
2024-05-02
Davis George Eric
EVP, Chief Legal Officer
1,850 @ $85.01$157K
Grant
2024-04-30
FUCHS HENRY J
President, Worldwide R&D
300 @ $68.65$21K
Grant
2024-04-30
Guyer Charles Greg
EVP, Chief Technical Officer
245 @ $68.65$17K
Grant10b5-1
2024-04-30
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
300 @ $68.65$21K
Grant10b5-1
2024-04-30
Davis George Eric
EVP, Chief Legal Officer
301 @ $68.65$21K
Grant10b5-1
2024-04-30
Mueller Brian
EVP, Chief Financial Officer
300 @ $68.65$21K